Cochrane systematic reviews in the field of addiction: Past and future

Journal of Evidence-Based Medicine

Volumn 6, Issue 4, 2013, Pages 221-228

  Amato, Laura ^a   Mitrova, Zuzana ^a   Davoli, Marina ^a  

^a DEPARTMENT OF EPIDEMIOLOGY   (Italy)

Author keywords

Cochrane Review; Drug and alcohol; Efficacy of intervention; Randomized trial; Systematic review

Indexed keywords

ALCOHOL; OPIATE DERIVATIVE; PSYCHOSTIMULANT AGENT;

ADDICTION; ALCOHOLISM; ARTICLE; COCHRANE LIBRARY; DRUG DEPENDENCE; EVIDENCE BASED MEDICINE; HUMAN; PRIORITY JOURNAL; SUBSTANCE ABUSE;

COCHRANE REVIEW; DRUG AND ALCOHOL; EFFICACY OF INTERVENTION; RANDOMIZED TRIAL; SYSTEMATIC REVIEW;

COOPERATIVE BEHAVIOR; EVIDENCE-BASED MEDICINE; HUMANS; INFORMATION DISSEMINATION; ORGANIZATIONS, NONPROFIT; REVIEW LITERATURE AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 84888389535     PISSN: 17565383     EISSN: 17565391     Source Type: Journal    
DOI: 10.1111/jebm.12067     Document Type: Article

References (42)

1. de Alba I, Samet JH, Saitz R. Burden of medical illness in drug- and alcohol dependent persons without primary care. American Journal of Addiction 2004; 13(1): 33-45.
2. Price RK, Risk NK, Murray KS, Virgo KS, Spitznagel EL. Twenty-five year mortality of us servicemen deployed in Vietnam: predictive utility of early drug use. Drug and Alcohol Dependence 2001; 64(3): 309-18.
3. Sørensen HJ, Jepsen PW, Haastrup S, Juel K. Drug-use pattern, comorbid psychosis and mortality in people with a history of opioid addiction. Acta Psychiatrica Scandinavica 2005; 111(3): 244-9.
4. Wahren CA, Brandt L, Allebeck P. Has mortality in drug addicts increased? A comparison of two hospitalized cohorts in Stockholm. International Journal of Epidemiology 1997; 26(6): 1219-26.
5. Bargagli AM, Hickman M, Davoli M, Perucci CA, Schifano P, Buster M, et al.; for the COSMO European Group. Drug related mortality and its impact on adult mortality in eight European countries. European Journal of Public Health 2006; 16(2): 198-202.
6. Ettner SL, Frank RG, Kessler RC. The impact of psychiatric disorder on labor market outcomes. Industrial and Labor Relations Review 1997; 51(1): 64-81.
7. Romelsjo A, Stenbacka M, Lundberg M, Upmark M. A population study of the association between hospitalization for alcoholism among employees in different socio-economic classes and the risk of mobility out of, or within, the workforce. European Journal of Public Health 2004; 14(1): 53-57.
8. Rehm J, Gnam W, Popova S, Baliunas D, Brochu S, Fischer B, et al. The costs of alcohol, illegal drugs, and tobacco in Canada. Journal of Studies on Alcohol and Drugs 2007; 68(6): 886-95.
9. Delaney A, Bagshaw SM, Ferland A, Laupland K, Manns B, Doig C. The quality of reports of critical care meta-analyses in the Cochrane Database of Systematic Reviews: an independent appraisal. Critical Care Medicine 2007; 35(2): 589-94.
10. Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, et al. Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. British Medical Journal 2000; 320(7234): 537-40.
11. Jørgensen AW, Katja L, Maric KL, Tendal B, Faurschou A, Gøtzsche PC. Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusions. BMC Medical Research Methodology 2008; 8(1): 60.
12. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Medicine 2007; 4(3): e78.
13. Moja LP, Telaro E, D'Amico R, Moschetti I, Coe L, Liberati A. Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. British Medical Journal 2005; 330(7499): 1053.
14. Olsen O, Middleton P, Ezzo J, Gøtzsche PC, Hadhazy V, Herxheimer A, et al. Quality of Cochrane Reviews: assessment of sample from 1998. British Medical Journal 2001; 323(7317): 829-32.
15. Tricco AC, Pham B, Brehaut J, Tetroe J, Cappellig M, Hopewell S, et al. An international survey indicated that unpublished systematic reviews exist. Journal of Clinical Epidemiology 2009; 62(6): 617-23.
16. Lang A, Edwards N, Fleiszer A. Empty systematic reviews: hidden perils and lessons learned. Journal of Clinical Epidemiology 2007; 60(6): 595-7.
17. Mandel D, Littner Y, Mimouni FB, Lubetzky R. Conclusiveness of the Cochrane neonatal reviews: a systematic analysis. Acta Paediatrica 2006; 95(10): 1209-12.
18. Pagliaro L, Bruzzi P, Bobbio M. Why are Cochrane hepato-biliary reviews undervalued by physicians as an aid for clinical decision-making? Digestive and Liver Disease 2010; 42(1): 1-5.
19. Davoli M, Ferri M. The Cochrane Review Group on drugs and alcohol. Addiction 2000; 95(10): 1473-4.
20. Amato L, Davoli M, Vecchi S, Ali R, Farrell M, Faggiano F. Cochrane systematic reviews in the field of addiction: what's there and what should be. Drug and Alcohol Dependence 2011; 113(2): 96-103.
21. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at www.cochrane-handbook.org (accessed 31 July 2013).
22. Chalmers I. Systematic reviews: insufficient evidence on which to base medicine. British Journal of Obstetrics and Gynaecology 1998; 105(11): 1235-6.
23. Dekkers OM, von Elm E, Algra A, Romijn JA, Vandenbroucke JP. How to assess the external validity of therapeutic trials: a conceptual approach. International Journal of Epidemiology 2009; 39(1): 89-94.
24. Garner S, Docherty M, Somner J, Sharma T, Choudhury M, Clarke M, et al. Reducing ineffective practice: challenges in identifying low-value health care using Cochrane systematic reviews. Journal of Health Services Research and Policy 2013; 18(1): 6-12.
25. National Collaborating Centre for Mental Health; National Institute for Health and Clinical Excellence. Alcohol-use Disorders: Diagnosis, Assessment and Management of Harmful Drinking and Alcohol Dependence. London: British Psychological Society and the Royal College of Psychatrists; 2011. (NICE CG115) [Issued February 2011]. Available at http://guidance.nice.org.uk (accessed 31 July 2013).
26. National Clinical Guideline Centre for acute and chronic conditions. Alcohol Use Disorders: Diagnosis and Clinical Management of Alcohol-Related Physical Complications. London: National Clinical Guideline Centre, Royal College of Physicians, 2010. (NICE CG100) [Issued June 2010]. Available at http://guidance.nice.org.uk/ (accessed 31 July 2013).
27. National Collaborating Centre for Mental Health; National Institute for Health and Clinical Excellence. Antisocial Personality Disorder: Treatment, Management and Prevention. London: British Psychological Society and the Royal College of Psychatrists; 2009. (NICE CG77) [Issued January 2009]. Available at http://guidance.nice.org.uk (accessed 31 July 2013).
28. National Collaborating Centre for Mental Health; National Institute for Health and Clinical Excellence. Drug Misuse: Psychosocial Interventions. London: British Psychological Society and the Royal College of Psychiatrists; 2007. (NICE CG51) [Issued July 2007]. Available at http://guidance.nice.org.uk (accessed 31 July 2013).
29. Australian National Drug Strategy. (2006). National clinical guidelines and procedures for the use of buprenorphine in the treatment of opioid dependence. Available at http://www.health.gov.au (accessed 31 July 2013).
30. Prodigy. 2005. Guidance for the use of methadone for the treatment of opioid dependence in primary care. In: National Health Service Clinical Knowledge Summaries. Prodigy 2005. Available at http://cks.library.nhs.uk (accessed 31 July 2013).
31. WHO Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. 2009. Available at http://www.who.int (accessed 31 July 2013).
32. Oxman AD, Lavis JN, Fretheim A. Use of evidence in WHO recommendations. Lancet 2007; 369(9576): 1883-9.
33. Danenberg E, Sorge LA, Wieniawski W, Elliott S, Amato L, Scholten WK. Modernizing methodology for the WHO assessment of substances for the international drug control conventions. Drug and Alcohol Dependence 2013; 131(3): 175-81.
34. Davoli M, Amato L. La valutazione dell'outcome come strumento per migliorare la qualità delle cure. Medicina delle Dipendenze 2011; 4: 32-7.
35. Davoli M, Amato L. Do Cochrane Reviews provide useful information to guide policy and practice? The experience of the Cochrane drugs and alcohol group. Epidemiology and Psychiatric Sciences 2011; 20(3): 219-23.
36. Amato L, Davoli M. La ricerca epidemiologica nel campo delle dipendenze patologiche offre informazioni utili per orientare la pratica clinica e le decisioni di sanità pubblica? Medicina delle Dipendenze 2011; 4: 15-21.
37. Amato L, Mitrova Z, Davoli M. Sintesi delle revisioni sistematiche Cochrane sull'efficacia degli interventi di cessazione e prevenzione del fumo di tabacco. Pubblicazione ISS maggio 2011, available at www.iss.it/ofad (accessed 31 July 2013).
38. Minozzi S, Davoli M, Bargagli AM, Amato L, Vecchi S, Perucci CA. An overview of systematic reviews on cannabis and psychosis: discussing apparently conficliting results. Drug and Alcohol Review 2010; 29(3): 304-17.
39. Vecchi S, Belleudi V, Amato L, Davoli M, Perucci CA. Does direction of results of abstracts submitted to scientific conferences on drug addiction predict full publication? BMC Medical Research Methodology 2009; 9(1): 23.
40. Amato L. Efficacia dei trattamenti di prevenzione per l'uso di tabacco, alcol e sostanze stupefacenti nei giovani: una overview delle revisioni sistematiche della letteratura. Medicina delle Dipendenze 2012; 6: 29-35.
41. Liberati A. Need to realign patient-oriented and commercial and academic research. Lancet 2011; 378(9805): 1777-8.
42. Clarke L, Clarke M, Clarke T. How useful are Cochrane Reviews in identifying research needs? Journal of Health Services Research and Policy 2007; 12(2): 101-3.